Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch

J Clin Invest. 1996 Jul 1;98(1):100-7. doi: 10.1172/JCI118753.

Abstract

Analysis of a large number of unrelated bone marrow transplantations (BMT) has shown that HLA-DP incompatibility did not detectably influence the risk for acute graft-versus-host disease (aGVHD). Accordingly, it was proposed that HLA-DP determinants did not function as transplantation antigens in the same way as HLA-A, -B, or -DR. We have previously shown that HLA-DP (as well as HLA-A, -B, -DQ, or -DR)-specific T cells could be isolated from skin biopsies of patients who developed an aGVHD after semiallogeneic BMT. Nevertheless, whether a single HLA-DP mismatched allele could induce a detectable allo-specific reaction in vivo after BMT remained to be established. To directly address this issue we studied one patient who presented aGVHD after receiving purified CD34+ bone marrow (BM) cells from an unrelated donor with a single HLA-DP mismatch in the GVHD direction. To characterize the immunological events associated with GVHD, we analyzed the peripheral T cell repertoire, the T cell receptor Vbeta diversity, and the specificity of T cells invading a skin biopsy at the onset of GVHD. Our results demonstrated that a large fraction of skin-infiltrating lymphocytes, which expressed diverse T cell receptors, were reactive against this single HLA-DPB1 *0501 mismatch and consequently that a single HLA-DP mismatch between BM donor and recipient can activate a strong T cell response in vivo.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Antigens, CD / analysis
  • Base Sequence
  • Bone Marrow Transplantation / adverse effects*
  • Cell Movement
  • Clone Cells / immunology
  • Female
  • Flow Cytometry
  • Graft vs Host Disease / etiology
  • Graft vs Host Disease / immunology*
  • HLA-DP Antigens / immunology*
  • HLA-DP beta-Chains
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Middle Aged
  • Molecular Sequence Data
  • Receptors, Antigen, T-Cell, alpha-beta / immunology
  • Skin / immunology
  • Skin / pathology
  • T-Lymphocytes / immunology*

Substances

  • Antigens, CD
  • HLA-DP Antigens
  • HLA-DP beta-Chains
  • HLA-DPB1 antigen
  • Receptors, Antigen, T-Cell, alpha-beta